Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-017710
Filing Date
2020-06-25
Accepted
2020-06-25 20:02:59
Documents
2
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7926
2 EX-24 DOCUMENT attachment1.htm EX-24 4696
  Complete submission text file 0000899243-20-017710.txt   14002
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address
Valliant John (Reporting) CIK: 0001813574 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990645